Form 8-K - Current report:
SEC Accession No. 0000950170-22-012554
Filing Date
2022-07-08
Accepted
2022-07-08 17:00:48
Documents
13
Period of Report
2022-07-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K itrm-20220707.htm   iXBRL 8-K 51851
2 EX-99.1 itrm-ex99_1.htm EX-99.1 31153
  Complete submission text file 0000950170-22-012554.txt   205796

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT itrm-20220707_lab.xml EX-101.LAB 13862
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT itrm-20220707_pre.xml EX-101.PRE 10215
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT itrm-20220707.xsd EX-101.SCH 2469
7 EXTRACTED XBRL INSTANCE DOCUMENT itrm-20220707_htm.xml XML 4669
Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38503 | Film No.: 221075154
SIC: 2834 Pharmaceutical Preparations